| 中文名称 |
(2R,3aR,11aS,12aR,14aR,Z)-N-(环丙基磺酰基)-2-((2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基喹啉-4-基)氧基)-5-甲基-4,14-二氧代-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-十四氢环戊二烯并[c]环丙并[g][1,6]二氮杂环十四烯-12a(1H)-甲酰胺 |
| 中文别名 |
(2R,3aR,10Z,11aS,12aR,14aR)-N-(环丙基磺酰基)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-十四氢-2-[[7-甲氧基-8-甲基-2-[4-(1-甲基乙基)-2-噻唑基]-4-喹啉基]氧基]-5-甲基-4,14-二氧代环戊并[c]环丙并[g][1,6]二氮杂环十四烯-12a(1H)-甲酰胺;(2R,3AR,10Z,11AS,12AR,14AR)-N-(环丙基磺酰基)-2,3,3A,4,5,6,7,8,9,11A,12,13,14,14A-十四氢-2-[[7-甲氧基-8-甲基-2-[4-(1-甲基乙基)-2-噻唑基]-4-喹啉;Simeprevir(TMC 435350) 抑制剂;Simeprevir标准品;司美匹韦;西米普韦;西米普韦中间体 |
| 英文名称 |
(2R,3aR,11aS,12aR,14aR,Z)-N-(Cyclopropylsulfonyl)-2-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)-5-methyl-4,14-dioxo-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carbo |
| 英文别名 |
(2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1;Simeprevir;(2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxocyc;Olysio (TN);Simeprivir;simprevir;TMC 435350;(2R,11aS,12aR,14aR,Z)-N-(cyclopropylsulfonyl)-2-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)-5-methyl-4,14-dioxo-1,2,3,3a,4,5,6,7,8,9,11a,12,12a,13,14,14a-hexadecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a-carboxamide;TMC435;TMC-435350;9WS5RD66HZ;TMC435350;Simeprevir [USAN:INN];DB06290;(1R,4R,7Z,15R,17R)-N-Cyclopropylsulfonyl-17-[7-methoxy-8-methyl-2-(4-propan-2-yl-1,3-thiazol-2-yl)qu |
| CAS号 |
923604-59-5 |
| 分子式 |
C38H47N5O7S2 |
| 分子量 |
749.96 |
微信公众号
